Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human

In 1871, the observation of yellowish nodules in the enlarged spleen of a cow was considered to be the first reported case of bovine leukemia. The etiological agent of this lymphoproliferative disease, bovine leukemia virus (BLV), belongs to the deltaretrovirus genus which also includes the related...

Descripción completa

Detalles Bibliográficos
Autores principales: Gillet, Nicolas, Florins, Arnaud, Boxus, Mathieu, Burteau, Catherine, Nigro, Annamaria, Vandermeers, Fabian, Balon, Hervé, Bouzar, Amel-Baya, Defoiche, Julien, Burny, Arsène, Reichert, Michal, Kettmann, Richard, Willems, Luc
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1839114/
https://www.ncbi.nlm.nih.gov/pubmed/17362524
http://dx.doi.org/10.1186/1742-4690-4-18
Descripción
Sumario:In 1871, the observation of yellowish nodules in the enlarged spleen of a cow was considered to be the first reported case of bovine leukemia. The etiological agent of this lymphoproliferative disease, bovine leukemia virus (BLV), belongs to the deltaretrovirus genus which also includes the related human T-lymphotropic virus type 1 (HTLV-1). This review summarizes current knowledge of this viral system, which is important as a model for leukemogenesis. Recently, the BLV model has also cast light onto novel prospects for therapies of HTLV induced diseases, for which no satisfactory treatment exists so far.

Ejemplares similares